Effects of lercanidipine hydrochloride versus felodipine sustained-release on day-to-day home blood pressure variability

References

• Kikuya M, Ohkubo T, Metoki H, et al. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama Study. Hypertension 2008;52:1045-50
   PubMed Web of Science ®Google Scholar
• Scisney-Matlock M, Grand A, Steigerwalt SP, et al. Reliability and reproducibility of clinic and home blood pressure measurements in hypertensive women according to age and ethnicity. Blood Press Monit 2009;14:49-57
   PubMed Web of Science ®Google Scholar
• Sakuma M, Imai Y, Nagai K, et al. Reproducibility of home blood pressure measurement over a 1-year period. Am J Hypertens 1997;10(7 pt 1):798-803
   PubMed Web of Science ®Google Scholar
• Drawz PE, Abdalla M, Rahman M. Blood pressure measurement: clinic, home, ambulatory, and beyond. Am J Kidney Dis 2012;60:449-62
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Howard SC, Dolan E, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol 2010;9:469-80
   PubMed Web of Science ®Google Scholar
• Webb AJ, Wilson M, Lovett N, et al. Response of day-to-day home blood pressure variability by antihypertensive drug class after transient ischemic attack or nondisabling stroke. Stroke 2014;45:2967-73
   PubMed Web of Science ®Google Scholar
• Borghi C. Lercanidipine in hypertension. Vasc Health Risk Manag 2005;1:173-82
   PubMedGoogle Scholar
• Wu Y, Xu M, Wang H, et al. Lercanidipine hydrochloride versus felodipine sustained release for mild-to-moderate hypertension: a multi-center, randomized clinical trial. Curr Med Res Opin 2015;31:171-6
   PubMed Web of Science ®Google Scholar
• Bilo G, Giglio A, Styczkiewicz K, et al. A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J Hypertens 2007;25:2058-66
   PubMed Web of Science ®Google Scholar
• Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366:895-906
   PubMed Web of Science ®Google Scholar
• Floras JS. Blood pressure variability: a novel and important risk factor. Can J Cardiol 2013;29:557-563
   PubMed Web of Science ®Google Scholar
• Johansson JK, Niiranen TJ, Puukka PJ, et al. Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn–Home Study. Hypertension 2012;59:212-18
   PubMed Web of Science ®Google Scholar
• Zhang Y, Agnoletti D, Safar ME, et al. Effect of antihypertensive agents on blood pressure variability: the Natrilix SR Versus Candesartan and Amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study. Hypertension 2011;58:155-60
   PubMed Web of Science ®Google Scholar
• Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003;107:1401-6
   PubMed Web of Science ®Google Scholar
• Pierdomenico SD, Pierdomenico AM, Cuccurullo F. Morning blood pressure surge, dipping, and risk of ischemic stroke in elderly patients treated for hypertension. Am J Hypertens 2014;27:564-70
   PubMed Web of Science ®Google Scholar
• Matsui Y, Equchi K, Shibasaki S, et al. Association between morning – evening difference in home blood pressure and cardiac damage in untreated hypertensive patients. J Hypertens 2009;27:712-20
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010;375:895-905
   PubMed Web of Science ®Google Scholar
• Iqbal P, Stevenson L. Cardiovascular outcomes in patient with normal and abnormal 24-hour ambulatory blood pressure monitoring. Int J Hypertens 2010;12:786912
   Google Scholar
• Romito R, Pansini MI, Perticone F, et al. Comparative effect of lercanidipine, felodipine, and nifedipine GITS on blood pressure and heart rate in patients with mild to moderate arterial hypertension: the Lercanidipine in Adults (LEAD) Study. J Clin Hypertens (Greenwich) 2003;5:249-53
   PubMedGoogle Scholar
• Matsui Y, O’Rouke MF, Hoshide S, et al. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study. Hypertension 2012;59:1132-8
   PubMed Web of Science ®Google Scholar
• Julien C. Pharmacological attenuation of blood pressure variability. Acta Pharmacol Sin 2005;26:1288-9
   PubMed Web of Science ®Google Scholar
• Mancia G, Parati G, Pomidossi G, et al. Arterial baroreflexes and blood pressure and heart rate variabilities in humans. Hypertension 1986;8:147-53
   PubMed Web of Science ®Google Scholar
• Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005;111:1777-83
   PubMed Web of Science ®Google Scholar
• Jula A, Puukka P, Karanko H. Multiple clinic and home blood pressure measurements versus ambulatory blood pressure monitoring. Hypertension 1999;34:261-6
   PubMed Web of Science ®Google Scholar
• Gaborieau V, Delarche N, Gosse P. Ambulatory blood pressure monitoring versus self-measurement of blood pressure at home: correlation with target organ damage. J Hypertens 2008;26:1919-27
   PubMed Web of Science ®Google Scholar